共 50 条
- [31] ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2009, 2
- [34] Multi-targeted combinations of liposomal drugs for cancer chemotherapy [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
- [35] Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors [J]. MOLECULES, 2018, 23 (10):
- [37] Synergistic antitumor activity of the combination of the multi-targeted tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines [J]. EJC SUPPLEMENTS, 2006, 4 (12): : 123 - 123
- [39] E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion [J]. BMC Cancer, 11
- [40] Effects of a multi-targeted receptor tyrosine kinase inhibitor on radiosentization of head and neck squamous cell carcinoma [J]. JOURNAL OF IMMUNOLOGY, 2012, 188